Atlantic Union Bankshares Corp Novartis Ag Transaction History

Atlantic Union Bankshares Corp

$1.61 Billion
Q4 2024

A detailed history of Atlantic Union Bankshares Corp transactions in Novartis Ag stock. As of the latest transaction made, Atlantic Union Bankshares Corp holds 17,503 shares of NVS stock, worth $1.92 Million. This represents 0.11% of its overall portfolio holdings.

Number of Shares

17,503

Previous 17,711 1.17%

Holding current value

$1.92 Million

Previous $2.04 Million 16.4%

% of portfolio

0.11%

Previous 0.13%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 07, 2025	SELL	$96.78 - $117.18 $20,130 - $24,373	-208 Reduced 1.17%	17,503 $1.7 Million
Q3 2024 Nov 14, 2024	SELL	$106.13 - $120.89 $18,042 - $20,551	-170 Reduced 0.95%	17,711 $2.04 Million
Q2 2024 Jul 24, 2024	SELL	$92.57 - $107.37 $12,589 - $14,602	-136 Reduced 0.75%	17,881 $1.9 Million
Q1 2024 Apr 16, 2024	SELL	$95.27 - $108.47 $128,519 - $146,326	-1,349 Reduced 6.97%	18,017 $1.74 Million
Q4 2023 Jan 19, 2024	SELL	$92.27 - $101.54 $196,627 - $216,381	-2,131 Reduced 9.91%	19,366 $1.96 Million
Q3 2023 Oct 20, 2023	SELL	$94.73 - $105.13 $115,002 - $127,627	-1,214 Reduced 5.35%	21,497 $2.19 Million
Q2 2023 Jul 11, 2023	SELL	$92.52 - $104.91 $74,386 - $84,347	-804 Reduced 3.42%	22,711 $2.29 Million
Q1 2023 May 08, 2023	SELL	$80.03 - $92.81 $105,399 - $122,230	-1,317 Reduced 5.3%	23,515 $2.16 Million
Q4 2022 Feb 09, 2023	SELL	$75.55 - $92.52 $50,542 - $61,895	-669 Reduced 2.62%	24,832 $2.25 Million
Q3 2022 Oct 25, 2022	SELL	$74.61 - $87.26 $225,844 - $264,136	-3,027 Reduced 10.61%	25,501 $1.94 Million
Q2 2022 Jul 21, 2022	SELL	$80.52 - $93.75 $111,359 - $129,656	-1,383 Reduced 4.62%	28,528 $2.41 Million
Q1 2022 Apr 26, 2022	SELL	$80.11 - $90.62 $350,881 - $396,915	-4,380 Reduced 12.77%	29,911 $2.63 Million
Q4 2021 Jan 19, 2022	SELL	$79.7 - $88.13 $1.24 Million - $1.37 Million	-15,579 Reduced 31.24%	34,291 $3 Million
Q3 2021 Oct 26, 2021	SELL	$81.78 - $95.14 $842,579 - $980,227	-10,303 Reduced 17.12%	49,870 $4.08 Million
Q2 2021 Jul 26, 2021	SELL	$85.24 - $94.15 $846,177 - $934,627	-9,927 Reduced 14.16%	60,173 $5.49 Million
Q1 2021 May 04, 2021	BUY	$83.5 - $98.47 $64,545 - $76,117	773 Added 1.12%	70,100 $5.99 Million
Q4 2020 Feb 01, 2021	BUY	$78.07 - $94.43 $51,682 - $62,512	662 Added 0.96%	69,327 $6.55 Million
Q3 2020 Oct 16, 2020	BUY	$82.14 - $91.0 $2,217 - $2,457	27 Added 0.04%	68,665 $5.97 Million
Q2 2020 Jul 15, 2020	BUY	$80.93 - $91.1 $143,974 - $162,066	1,779 Added 2.66%	68,638 $6 Million
Q1 2020 Apr 10, 2020	SELL	$70.67 - $99.01 $166,074 - $232,673	-2,350 Reduced 3.4%	66,859 $5.51 Million
Q4 2019 Jan 14, 2020	BUY	$84.35 - $95.37 $26,570 - $30,041	315 Added 0.46%	69,209 $6.55 Million
Q3 2019 Oct 17, 2019	SELL	$85.54 - $94.26 $11,547 - $12,725	-135 Reduced 0.2%	68,894 $5.99 Million
Q2 2019 Jul 23, 2019	BUY	$75.4 - $92.8 $2.56 Million - $3.15 Million	33,987 Added 96.99%	69,029 $6.3 Million
Q1 2019 Apr 10, 2019	SELL	$75.32 - $86.15 $249,007 - $284,811	-3,306 Reduced 8.62%	35,042 $3.37 Million
Q4 2018 Jan 14, 2019	SELL	$73.66 - $82.02 $33,073 - $36,826	-449 Reduced 1.16%	38,348 $3.29 Million
Q3 2018 Oct 11, 2018	SELL	$66.94 - $77.43 $3,547 - $4,103	-53 Reduced 0.14%	38,797 $3.34 Million
Q2 2018 Jul 12, 2018	SELL	$64.91 - $73.36 $27,132 - $30,664	-418 Reduced 1.06%	38,850 $2.94 Million
Q1 2018 Apr 11, 2018	BUY	$70.39 - $84.15 $116,777 - $139,604	1,659 Added 4.41%	39,268 $3.18 Million
Q4 2017 Jan 10, 2018	BUY	$72.33 - $77.64 $25,098 - $26,941	347 Added 0.93%	37,609 $3.16 Million
Q3 2017 Oct 13, 2017	BUY	$74.14 - $77.27 $2.76 Million - $2.88 Million	37,262	37,262 $3.2 Million

Others Institutions Holding NVS

# of Institutions

1,473

Shares Held

134M

Call Options Held

1.31M

Put Options Held

1.56M

View Full List

About NOVARTIS AG

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $236B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

More about NVS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Atlantic Union Bankshares Corp, based on Form 13F filings with the SEC.

News

Stay updated on Atlantic Union Bankshares Corp with notifications on news.

Account

Atlantic Union Bankshares Corp Novartis Ag Transaction History